Out-of-hospital treatment of acute myocardial infarction in Andalusia, Spain;Tratamiento extrahospitalario del infarto agudo de miocardio en Andalucía

Revista Espanola de Cardiologia

Volumn 58, Issue 11, 2005, Pages 1287-1293

  Mellado Vergel, Francisco J ^a,c   Ortiz, Fernando Rossell ^a   Bailén, Manuel Ruiz ^b   Vivar Díaz, Itziar ^a   Langa Valdivieso, José ^a   Martinez Faure, Jesús E ^a   González Lobato, Ismael ^a   Perea Díaz, Juan C ^a   Alonso Sánchez, José A ^a   Plaza Moreno, Félix ^a   López López, Patrocinio ^a   Rosa Jiménez, Joaquín ^a   Paz Rodríguez, Miguel A ^a   Villarreal Santos, María D ^a   Delgado Rojas, Gabriel ^a   Garrido Ramos, Juan A ^a   Marfil Robles, Jose L ^a   Martínez Lara, Manuela ^a   Alonso Urbita, Javier ^a   Reina Toral, Antonio ^d   Aguayo de Hoyos, Eduardo ^d   Benitez Parejo, José ^e   Ibáñez Amat, Alicia ^e   Díaz Góngora, Angeles ^e   more..

^a Empresa Pública de Emergencias Sanitarias EPES 061   (Spain)

^b Hosp Univ Ciudad de Jaén   (Spain)

^c Empresa Pública de Emergencias Sanitarias ^*  (Spain)

^d Sociedad Andaluza de Medicina Familiar Y Comunitara SAMFyC   (Spain)

^e Mantenimiento de la base PEFEX ^*

Author keywords

Acute coronary syndrome; Fibrinolysis; Medical emergency; Myocardial infarction; Out of hospital treatment; Thrombolysis

Indexed keywords

ALTEPLASE; TENECTEPLASE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGE; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; EMERGENCY TREATMENT; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PARAMEDICAL PERSONNEL; REGISTER; RISK ASSESSMENT; RISK FACTOR; SPAIN; ST SEGMENT ELEVATION; STROKE; SYSTOLIC BLOOD PRESSURE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 30044434626     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1885-5857(06)60416-7     Document Type: Article

References (27)

1. Marrugat J, Elosua R, Marti H. Epidemiología de la cardiopatía isquémica en España: estimación del número de casos y de las tendencias entre 1997 y 2005. Rev Esp Cardiol 2002;55:337-46.
2. O'Doherty M, Tayler DI, Quinn E, Vincent R, Chamberlain DA. Five hundred patients with myocardial infarction monitored within one hour of symptoms. BMJ (Clin Res Ed). 1983;286:1405-8.
3. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311-22.
4. Boersma E, Maspirina AC, Deckers JW, Simoons ML. Early thrombolytic tretament in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996;348:771-5.
5. Morrison LJ, Verbeck PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospital trombolysis for acute myocardial infarction. A meta-analysis. JAMA. 2000;283:2686-92.
6. Mathew TP, Menown IBA, McCarty D, Gracey H, Hill L, Adgey AAJ. Impact of pre-hospital care in patients with acute myocardial infarction compared with those first managed in-hospital. Eur Heart J. 2003;24:161-71.
7. Arós F, Cuñat J, Loma Osorio A, Torrado, E, Bosch X, Rodríguez JJ, et al. Tratamiento del infarto agudo de miocardio en España en el año 2000. El estudio PRIAMHO II. Rev Esp Cardiol. 2003;56:1165-73.
8. Aguayo E, Reina A, Colmenero M, Barranco M, Pola MD, Jiménez MM, et al. Análisis de los retrasos en el tratamiento del síndrome coronario agudo. Datos del registro ARIAM. Med Intens. 1999;23:280-7.
9. Sala J, Marrugat J, Masiá R, Porta-Serra M. Improvement in survival after myocardial infarction between 1978-85 and 1986-88 in the REGICOR study. Eur Heart J. 1995;16:779-84.
10. National Registry of Myocardial Infarction faccedido 8 Jul 05). Disponible en: http//www.nrmi.org/index.html
11. a revisión. Modificación clínica. Madrid: Ministerio de Sanidad y Consumo; 1996. p. 375-6.
12. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al. ACC clinical data standards. J Am Coll Cardiol 2001;38:2114-30.
13. GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-82.
14. Ruiz Bailén M, Aguayo de Hoyos E, Ramos Cuadra JA, Díaz Castellanos MA, Issa Khozouz Z, Reina Toral A, et al. Influence of age on clinical course, management and mortality of acute myocardial infarction in the Spanish population. Int J Cardiol. 2002;85:285-96.
15. Arós F, Loma-Osorio A, Alonso A, Alonso JJ, Cabades A, Coma-Canella I, et al. Guías de actuación clínica de la Sociedad Española de Cardiología en el infarto agudo de miocardio. Rev Esp Cardiol. 1999;52:919-56.
16. Ruiz Bailén M, Aguayo de Hoyos E, Hurtado Ruiz B, Reina Toral A, Díaz Castellanos MA, Issa Khozouz Z. ARIAM Group. Alteplase: double bolus versus accelerated regimen. Med Sci Monit. 2002; 8:185-92.
17. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. The ASSENT-3 Investigators. Lancet. 2001;358:605-13.
18. Cardiopatía isquémica en España. Análisis de la situación 2001. Madrid: Ministerio de Sanidad y Consumo. Sociedad Española de Cardiología; 2001. p.74-5.
19. Rogers WJ, Canto JG, Lambrew CT. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 2000;36:2056-63.
20. Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, McFadden P, Dubien PY, et al. Primary angioplasty versus prehospital fibrinolysis in acute mycardial infarction: a randomised study. Lancet. 2000;360:825-9.
21. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary. A report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients With Acute Myocardial Infarction). 2004. Disponible en: www.acc.org/clinical/guidelines/stemi/index.pdf
22. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Keith Fox K, et al. Task Force Report Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24:28-66.
23. Aguayo de Hoyos E, Reina Toral A, Ruiz Bailén M, Colmenero Ruiz M, García Delgado M. La asistencia prehospitalaria en los sindromes coronarios agudos. Experiencia del grupo ARIAM. Aten Primaria. 2001;27:478-83.
24. The European Myocardial Infarction Projet Group. Prehospital thrombolytic therapy in patient with suspected acute myocardial infarction. N Engl J Med. 1993;329:383-9.
25. GREAT Group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. BMJ. 1992;305:548-53.
26. Wallentin L, Goldstein P, Armstrong PW, Granger CB, Adgey AAJ, Arntz HR, et al. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting. Circulation. 2003;108:135-42.
27. Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation. 2003;108:2828-30.